Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Remote Pharmacy

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Remote Pharmacy head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 246 · Grade C

Remote Pharmacy

Visit Remote Pharmacy Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 66 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Remote Pharmacy a bad call — it's best for readers comparing oral and injectable choices who can obtain the complete selected-term price and confirm their assigned care team. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
78
Supply Reliability
95
68
Transparency
90
52
Access Breadth
93
56
Clinical Oversight
92
74
Track Record
88
63
CoreAge RxBrief Score 94 · 66Remote Pharmacy

Price, coverage & the tracker

CoreAge RxRemote Pharmacy
Brief Score94/100 (A)66/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm the full commitment

Compounded injections advertised as low as $100/month; oral tablets from $167/month.

Selected term and initial payment are unconfirmed; these are starting advertisements.

Full price details

Complete selected-term quote unknown; compounded semaglutide injections advertised as low as $100/month; oral tablets from $167/month, with plan commitment and initial total unconfirmed

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm the full commitment

Compounded injections advertised as low as $125/month; oral tablets from $257/month.

Selected term and initial payment are unconfirmed; these are starting advertisements.

Full price details

Complete selected-term quote unknown; compounded tirzepatide injections advertised as low as $125/month; oral tablets from $257/month, with plan commitment and initial total unconfirmed

CoverageUS only; restrictions by state, confirmed at intakeFAQ excludes Mississippi and New Mexico for compounded semaglutide and excludes US territories; other medication and pharmacy restrictions may apply
Brand-name accessNot confirmedOzempic and Wegovy are labeled coming soon on the current weight-loss catalog, not confirmed active options.
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Remote Pharmacy: Injection advertisements start at $100/$125 monthly; full selected-term totals remain unconfirmed. Cancellation after consultation but before shipment deducts $30.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.